Bill Text: NJ A3269 | 2022-2023 | Regular Session | Introduced


Bill Title: Requires health care facilities to reports cases of amyotrophic lateral sclerosis.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2022-03-07 - Introduced, Referred to Assembly Health Committee [A3269 Detail]

Download: New_Jersey-2022-A3269-Introduced.html

ASSEMBLY, No. 3269

STATE OF NEW JERSEY

220th LEGISLATURE

 

INTRODUCED MARCH 7, 2022

 


 

Sponsored by:

Assemblyman  DANIEL R. BENSON

District 14 (Mercer and Middlesex)

 

 

 

 

SYNOPSIS

     Requires health care facilities to reports cases of amyotrophic lateral sclerosis.

 

CURRENT VERSION OF TEXT

     As introduced.

  


An Act concerning amyotrophic lateral sclerosis and supplementing Title 26 of the Revised Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    a.  As used in this section:

     "Health care facility" means a health care facility licensed by the Department of Health pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.)

     b.    Consistent with federal and State privacy laws, the Department of Health shall require health care facilities to confidentially report to the department all known and suspected cases of amyotrophic lateral sclerosis in a manner to be specified by the department. 

     c.     The department shall record and compile information received pursuant to this section for research purposes only.

 

     2.    This act shall take effect immediately.

 

 

STATEMENT

 

     This bill requires health care facilities to reports cases of amyotrophic lateral sclerosis.

     The bill provides that consistent with federal and State privacy laws, the Department of Health (department) is to require health care facilities to confidentially report to the department all known and suspected cases of amyotrophic lateral sclerosis in a manner to be specified by the department.  The department is to record and compile information received pursuant to the bill's provisions for research purposes only.

feedback